News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Why Eli Lilly (LLY) Execs are Bullish About Its Alzheimer's Drug Solanezumab     8/23/2016
Eli Lilly (LLY)'s Incoming CEO May Carry First Alzheimer's Drug Across The Finish Line     8/22/2016
Anavex (AVXL) Plummeted on Phase IIa Alzheimer's Results "Considered" Positive     7/28/2016
TauRx Pharma's Much-Watched Alzheimer's Drug Flops in Trial     7/27/2016
Biogen (BIIB)'s Partner AC Immune SA Reels In $43.5 Million for Alzheimer's and Neurodegenerative Diseases R&D     5/10/2016
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response     4/28/2016
A Day After The Pfizer (PFE)-Allergan (AGN) Deal Dies, Allergan Inks Potential $3.3 Billion Alzheimer’s Deal with Heptares     4/11/2016
AstraZeneca PLC (AZN), Eli Lilly (LLY) Alzheimer's Drug Enters Final Testing Stage, Astra Earns $100 Million     4/8/2016
TauRx Pharma Co-Founder's 30-Year Alzheimer's Quest May Bear Fruit in July     3/21/2016
Eli Lilly (LLY) Dropped After Primary Goal of Alzheimer's Study Was Changed     3/18/2016
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate     3/11/2016
As Pfizer (PFE) Kills Alzheimer's Trial, Axovant (AXON) Stock Plunges     2/3/2016
Denali, Helmed by Former Genentech (RHHBY) Execs, Takes Space in South San Francisco Site     1/20/2016
Pint-Sized Anavex (AVXL) May Soon Have the Data to Prove Biogen (BIIB) and Eli Lilly (LLY)'s Alzheimer's Approach is All Wrong     12/10/2015
Anavex (AVXL) May Have Just Become a Target for Biogen (BIIB) and Eli Lilly (LLY)     12/2/2015

News from Around the Web
This Helmet Shows What's Going On Inside A Person's Brain, Department of Energy Study     8/23/2016
Diet And Exercise Could Stop Alzheimer's From Forming, UCLA Study     8/17/2016
Treatment Option For Alzheimer’s Disease Possible, University of Manchester Study     8/15/2016
New Biochip-Based Blood Test Detects Elevated Risk for Alzheimer's Disease, Randox Reveals     8/4/2016
Deep Brain Stimulation for Early Alzheimer's? Toronto Western Hospital Study     7/29/2016
How Your Sight And Smell Could Be The Key For Early Detection Of Alzheimer's, Studies Reported at AAIC 2016 Reveal     7/27/2016
These Kinds Of Jobs Can Help Protect Your Brain From Alzheimer's, University of Wisconsin-Madison Study     7/26/2016
Alzheimer's May Hamper Ability To Perceive Pain, Vanderbilt University Study Shows     7/21/2016
How Do You Regulate The Digital Health Revolution?     7/19/2016
Vaccine Could Stop Alzheimer’s In Its Tracks, Flinders University Study     7/18/2016
Alzheimer's Gene May Show Effects In Childhood, University of Hawaii Study     7/14/2016
Estrogen Patch In Newly Postmenopausal Women May Reduce Alzheimer's Risk, Mayo Clinic Study     7/13/2016
Alzheimer’s Detected Before Symptoms Via New Eye Technology, University of Minnesota Study     7/12/2016
Genetic Risk Factors For Alzheimer's Disease May Be Detectable Even In Young Adults, Massachusetts General Hospital Study     7/7/2016
Cannabinoids Remove Plaque-Forming Alzheimer's Proteins From Brain Cells, Salk Institute for Biological Studies Study     6/30/2016

Press Releases
Eli Lilly (LLY) And AstraZeneca PLC (AZN) Receive FDA Fast Track Designation For AZD3293, An Investigational Treatment For Early Alzheimer's Disease     8/22/2016
Axovant (AXON) Announces Expansion Of Dementia Pipeline And Reports Financial Results For The First Fiscal Quarter Ended June 30, 2016     8/16/2016
Neurotrope Submits An Amended Protocol To The FDA For Its Phase 2b Clinical Trial Of Its Lead Drug Candidate, Bryostatin-1, For The Treatment Of Advanced Alzheimer's Disease     8/15/2016
CryoPort Expands Agreement With Stemedica Cell Technologies, Inc. To Support A Phase II Clinical Trial To Assess A Stem Cell Therapy For The Treatment Of Alzheimer's Disease     8/11/2016
Eisai Company (ESALY.PK) Release: U.S. FDA Confirms Sufficient Data To Advance Investigational Bace Inhibitor E2609 For Treatment Of Early Alzheimer’s Disease To PHASE III     8/10/2016
The Results Of Phase I Clinical Trial Of The Araclon Biotech Alzheimer's Vaccine Support Its Continuation     8/1/2016
Eli Lilly (LLY) Release: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease     7/28/2016
ProMis Neurosciences Announces Results In Two Presentations At The 2016 Alzheimer's Association International Conference     7/28/2016
Actinogen Medical Announces Landmark Research On Excess Cortisol And Alzheimer’s Disease     7/28/2016
Stemedica Cell Technologies, Inc. Begins First Clinical Trials In The U.S. Using Adult Allogeneic Stem Cells To Treat Alzheimer's Disease     7/27/2016
Alzheon Presents Positive Results Of ALZ-801 Clinical Studies That Lead To Advancement To Pivotal Phase III Study In Alzheimer's Patients With APOE4/4 Homozygous Genotype     7/25/2016
ProMis Neurosciences Announces New Program To Identify Novel Alzheimer's Disease Targets On Toxic Strains Of Protein Tau     7/25/2016
Alzheimer's Association Formal Education And Complex Work May Reduce The Negative Effects Of Bad Diet And Cerebrovascular Disease On Cognition     7/25/2016
Cytox Launches Breakthrough Genetic Biomarker Research Assay For Alzheimer’s Disease Risk Assessment     7/22/2016
Diversity Of Eli Lilly (LLY)'s Alzheimer's Disease Pipeline Showcased At The Alzheimer's Association International Conference 2016 (AAIC 2016)     7/21/2016

//-->